Description
An anti-peptic ulcer drug is a class
of drugs used for the treatment of most common ulcers in stomach and upper part
of small intestine. These drugs act by decreasing the levels of gastric acidity
or by enhancing the protection for mucosa. Major causes of peptic ulcer are
Helicobacter pylori (H. pylori) infection or due to long-term use of drugs such
as aspirin, ibuprofen and non-steroidal anti-inflammatory drugs (NSAIDs).
To
Read the Complete Report with TOC Visit:
http://www.marketresearchreports.biz/analysis-details/anti-peptic-ulcer-drugs-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019
Anti-peptic ulcer drugs market is
classified based on:
- Drug class
- Proton pump inhibitor
- H2 receptor antagonist
- Gastric mucosal protective
drugs
- Antacid
- Antibiotics
- Others
Some of the key players contributing
in anti-peptic ulcer market are AstraZeneca PLC, Daewoong Pharmaceutical
Co., Ltd., Eisai Co., Ltd., HeliCure AB, Ore Pharmaceuticals, Inc.,
Sihuan Pharmaceutical Holdings Group Ltd. and Takeda Pharmaceutical
Company Limited.
This research report analyzes this
market depending on its market segments, major geographies, and current
market trends. Geographies analyzed under this research report include
- North America
- Asia Pacific
- Europe
- Rest of the World
This report provides comprehensive analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years
This report is a complete study of
current trends in the market, industry growth drivers, and restraints.
It provides market projections for the coming years. It includes
analysis of recent developments in technology, Porter’s five force model
analysis and detailed profiles of top industry players. The report also
includes a review of micro and macro factors essential for the existing
market players and new entrants along with detailed value chain
analysis.
Contact
M/s Sheela
90 Sate Street, Suite
700
Albany, NY 12207
USA – Canada Toll
Free: 866-997-4948
No comments:
Post a Comment